Author:
Солтанова Ирада Фахраддинкызы
Publisher
Scientific Technologies LLC
Reference10 articles.
1. Bocanegra, A. and others. PD-L1 in systemic immunity uraveling its contribution to PD-1/PD-L1 blockade immunotherapy / A.Bocanegra, E.Blanco, H.Arasanz, L.Chocarro , M.Zuazo M., P.Morente, D.Escors, G.Kochan, G.Fernandez-Hinojal, R.Vera // International Journal of Molecular Sciences. ― 2020. Vol. 21. Issue 16. ― Pp. 1-17.
2. Chen Y. and others. Analysis of prognostic factors and clinical outcomes in uterine cervical carcinoma with isolated para-aortic lymph node recurrence. / Y.Chen, H.Lin, Ch.Wang // Am. J. Transl. Res. ― 2019, ― 11(12). ― Pp. 7492–7502.
3. Chen Y. and others. Distribution patterns of lymph node metastasis in early stage invasive cervical cancer / Y.Chen, C.Fang, K.Zhang et al // ― Baltimore: Medicine. ― 2020, Oct 16, ― 99 (42). ― Pp. 222-285.
4. Diggs, L.P. and others. Utility of PD-L1 immunohistochemystry assays for predicting PD-1/PD-L1 inhibitor response / L.P.Diggs, E.C.Hsueh // Biomarker Research. ― 2017. Vol. 5. Issue 1. ― Pp. 12.
5. Duruisseaux, M. and others. Efficacy of PD1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers / M.Duruisseaux, I.Rouquette, J.Adam, A.Cortot, A.Cazes, L.Gibault, D.Damotte, S.Lantuejoul // Annales de Pathologie. ― 2017. Vol. 37. Issue 1. ― Pp. 61-78.